Hepatitis C virus induced endothelial inflammatory response depends on the functional expression of TNFα receptor subtype 2

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Pircher, Joachim ^a   Czermak, Thomas ^a   Merkle, Monika ^a   Mannell, Hanna ^a   Krötz, Florian ^a   Ribeiro, Andrea ^a   Vielhauer, Volker ^a   Nadjiri, Jonathan ^a   Gaitzsch, Erik ^a   Niemeyer, Markus ^b   Porubsky, Stefan ^c   Gröne, Hermann Josef ^c   Wörnle, Markus ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYINOSINIC POLYCYTIDYLIC ACID; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VIRUS RECEPTOR; VIRUS RNA; CYTOKINE; DEAD BOX PROTEIN; IFIH1 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN; TNFRSF1B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CAPILLARY ENDOTHELIAL CELL; CELL ACTIVATION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; EXTRAVASATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LEUKOCYTE ROLLING; MEDIATOR RELEASE; MOUSE; MOUSE MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASCULITIS; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HEPACIVIRUS; HOST PATHOGEN INTERACTION; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME; VIROLOGY; WESTERN BLOTTING;

HEPATITIS C VIRUS;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DEAD-BOX RNA HELICASES; ENDOTHELIAL CELLS; GENE EXPRESSION; HEPACIVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCYTE ROLLING; MICE, INBRED C57BL; MICE, KNOCKOUT; POLY I-C; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME FACTORS; TOLL-LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84913598185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113351     Document Type: Article

References (42)

1. Poynard T, Yuen MF, Ratziu V, Lai CL (2003) Viral hepatitis C. Lancet 362: 2095-2100.
2. Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327: 1490-1495.
3. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, et al. (1991) Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 34: 1606-1610.
4. Perico N, Cattaneo D, Bikbov B, Remuzzi G (2009) Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4: 207-220.
5. Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, et al. (1994) Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96: 124-132.
6. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, et al. (1999) Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C Arthritis Rheum 42: 2204-2212.
7. Vassilopoulos D, Calabrese LH (2002) Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum 46: 585-597.
8. Wörnle M, Schmid H, Banas B, Merkle M, Henger A, et al. (2006) Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168: 370-385.
9. Wörnle M, Roeder M, Sauter M, Ribeiro A (2009) Role of matrix metalloproteinases in viral-associated glomerulonephritis. Nephrol Dial Transplant 24: 1113-1121.
10. Merkle M, Ribeiro A, Wörnle M (2011) TLR3 dependent regulation of cytokines in human mesangial cells: a novel role for IP-10 and TNFa in hepatitis C associated glomerulonephritis. Am J Physiol Renal Physiol 301: 57-69.
11. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680.
12. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3. Nature 413: 732-738.
13. Matsukura S, Kokubu F, Kurokawa M, Kawaguchi M, Ieki K, et al. (2007) Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells. Int Arch Allergy Immunol 143 Suppl 1:: 80-83.
14. Vitour D, Meurs EF (2007) Regulation of interferon production by RIG-I and LGP2: a lesson in selfcontrol. Sci STKE 384: 20.
15. Yount JS, Moran TM, López CB (2007) Cytokine-independent upregulation of MDA5 in viral infection. J Virol 81 7316-7319.
16. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, et al. (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99; 683-690.
17. Mannell H, Hammitzsch A, Mettler R, Pohl U, Krotz F (2010) Suppression of DNA-PKcs enhances FGF-2 dependent human endothelial cell proliferation via negative regulation of Akt. Cell Signal 22; 88- 96.
18. Baez S (1973) An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 5; 384-394.
19. Mannell H, Pircher J, Chaudhry DI, Alig SK, Koch EG, et al. (2012) ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression. Cardiovasc Res 93; 111-119.
20. Wörnle M, Schmid H, Merkle M, Banas B (2004) Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC Nephrol 5; 8.
21. Popvic ZV, Wang S, Papatriantafyllou M, Kaya Z, Porubsky S, et al. (2011) The proteiglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J Immunol 15; 6217-6226.
22. Pircher J, Merkle M, Wörnle M, Mannell H, Ribeiro A, et al. (2012) Prothrombotic effects of tumor necrosis factor alpha: implications for autoimmune disorders and their therapy with biological agents. Arthritis Res Ther 14: R225.
23. Terrier B, Semoun O, Saadoun D, Sène D, Resche-Rigon M, et al. (2011) Prognostic factors in hepatitis C virus patients with systemic vascultitis. Arthritis Rheum 63: 1748-57.
24. Terrier B, Sène D, Dechartres A, Saadoun D, Ortonne N, et al. (2011) Systemic vasculitis in patients with Hepatitis C virus infection with and without detectable mixed cryoglobulinemia. J Rheumatol 38: 104-110.
25. Trejo O, Ramos-Casals M, García-Carrasco M, Cervera R, Trejo O, et al. (2001) Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80: 252-262.
26. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Sebastiani M, et al. (2008) High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection. Am J Gastroenterol 103: 2488- 2494.
27. Antonelli A, Ferri C, Ferrari SM, Colaci M, Sansonno D, et al. (2009) Endocrine manifestations of hepatitis C virus infection. Nat Clin Pract Endocrinol Metab 5: 26-34.
28. Feldmann G, Nischalke HD, Nattermann J, Banas B, Berg T, et al. (2006) Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. Clin Cancer Res 12: 4491-4498.
29. Antonelli A, Ferri C, Ferrari SM, Ghiri E, Marchi S, et al. (2009) High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia. Clin Rheumatol 28: 1179-1185.
30. Kaplanski G, Maisonobe T, Marin V, Grès S, Robitail S, et al. (2005) Vascular cell adhesion molecule- 1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis Cassociated mixed cryoglobulinemia. J Hepatol 42; 334-340.
31. Karikó K, Bhuyan P, Capodici J, Weissmann D (2004) Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 172; 6545-6549.
32. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, et al. (2008) Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452; 591-597.
33. Farina G, York M, Collins C, Lafyatis R (2011) dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts. Ann Rheum Dis 70; 544-550.
34. Hägele H, Allam R, Pawar RD, Anders HJ (2009) Double-stranded RNA activates type I interferon secretion in glomerular endothelial cells via retinoic acid-inducible gene (RIG)-1. Nephrol Dial Transplant 24; 3312-3318.
35. Zimmer S, Steinmetz M, Asdonk T, Motz I, Coch C, et al. (2011) Activation of endothelial Toll-like receptor 3 impairs endothelial function. Cir Res 108: 1358-1366.
36. Lundberg AM, Drexler SK, Monaco C, Williams LM, Sacre SM, et al. (2007) Key differences in TLR3/ poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 110; 3245-3252.
37. Cocquerel L, Voisset C, Dubuisson J (2006) Hepatitis C virus entry: potential receptors and their biological functions. J Gen Virol 87; 1075-1084.
38. Burlone ME, Budkowska A (2009) Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J Gen Virol 90; 1055-1070.
39. Fletcher NF, Wilson GK, Murray J, Hu K, Lewis A, et al. (2012) Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142; 634-643.
40. Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10; 45-65.
41. Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P (2006) Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum 54; 3696-3706.
42. Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, et al. (2011) Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 10; 444-454.